TrialRadiation oncology (London, England)2026

Preliminary results from a phase II trial of spatially fractionated radiotherapy combined with immunotherapy and anti-angiogenic therapy in patients with bulky solid tumors: early evidence of promising efficacy and favorable safety.

Yuntao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.